Literature DB >> 2816921

Inappropriate increase in erythropoietin titers during chemotherapy.

E Piroso1, A J Erslev, J Caro.   

Abstract

Serial erythropoietin measurements by RIA were performed in six patients with acute leukemia treated by intensive chemotherapy. In all cases erythropoietin titers increased after the onset of treatment, although the hemoglobin concentration remained at stable values. Subsequently the erythropoietin titers gradually returned to baseline levels. In same patients this reduction occurred at the end of chemotherapy, in others coincident with infections and antibiotic therapy. In four patients this decrease occurred at the time of bone marrow recovery. The explanation for this inappropriate increase in erythropoietin titers is not clear but may be related to a direct or indirect effect of a suppressed marrow on sites of erythropoietin production or catabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816921     DOI: 10.1002/ajh.2830320403

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.

Authors:  R Canaparo; F Casale; E Muntoni; G P Zara; C Della Pepa; E Berno; N Pons; G Fornari; M Eandi
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.

Authors:  Per Olsson-Gisleskog; Philippe Jacqmin; Juan Jose Perez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers.

Authors:  Wojciech Krzyzanski; Elzbieta Wyska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-11       Impact factor: 3.000

4.  Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.

Authors:  Anne C Heatherington; Christian Dittrich; John T Sullivan; Greg Rossi; Johannes Schueller
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.

Authors:  M Wolff; W Jelkmann
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

6.  Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report.

Authors:  A C Heatherington; J Schuller; A J Mercer
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.